Back to Top Skip to main content Skip to sub-navigation

COVID-19 Booster Shots are Now Available – What You Need to Know

Image of Containers of the Pfizer COVID-19 vaccine. Each vial contains six doses for vaccination against the COVID-19 virus. Pfizer vaccines at Moody Air Force Base, Georgia, Sept. 9, 2021. Each Pfizer vial contains six doses for vaccination against the COVID-19 virus. (U.S. Air Force photo by Senior Airman Rebeckah Medeiros)

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

Booster shots of Pfizer-BioNTech's COVID-19 vaccine are now available at military medical treatment facility and Department of Defense vaccination sites.

Those eligible for a Pfizer-BioNTech booster shot may also get them at commercial sites, such as civilian pharmacies or doctors' offices

All COVID-19 vaccines, including Pfizer-BioNTech's booster dose, may be given at the same time as the influenza vaccine (or other vaccines which may be due).

Fully vaccinated is still defined by the Centers for Disease Control and Prevention (CDC) as completing the 2-dose series for Pfizer-BioNTech or Moderna vaccines and the 1 dose for Johnson & Johnson/Janssen vaccine.

Booster Shots

Booster shots are now formally recommended for certain groups of people under an Emergency Use Authorization, according to recent announcements from the Food and Drug Administration (FDA) and the CDC.

For now, eligibility for a booster shot is limited to those who previously received a two-dose Pfizer-BioNTech COVID-19 vaccine for their initial vaccination.

At this time, booster shots are not recommended for those who initially received the Moderna two-dose vaccine and the Johnson & Johnson/Janssen single-dose vaccine or a mixed series of vaccines. However, those two populations will likely be recommended to receive a booster shot, and a formal recommendation for that may be forthcoming later this year as additional data are reviewed, according to the CDC.

Eligibility to voluntarily receive a single Pfizer-BioNTech booster vaccine includes people who are:

  • 65 years and older and residents in long-term care facilities
  • 18 and older in long-term care settings
  • 50-64 with underlying medical conditions
  • 18-49 with underlying medical conditions based on their individual benefits and risks
  • 18-64 who are at increased risk of COVID-19 exposure and transmission because of occupational or institutional settings such as teachers, frontline health care workers and essential workers, and those incarcerated, based on their individual benefits and risks.

To become eligible for a booster shot, there is a there is a six-month waiting period after the completion of the second dose of the Pfizer-BioNTech 2-dose vaccine.

Booster doses are not currently part of the DOD or federal worker mandates for COVID-19 vaccine requirements.

Proof of an underlying condition or an occupational risk is not required to receive a booster dose at an MTF or DOD vaccination site, and self-reporting of a condition eligible for a booster shot is allowed at any site where vaccines are available.

Comirnaty

The Pfizer-BioNTech COVID-19 vaccine is also known as the "Pfizer-BioNTech Comirnaty vaccine." The initial Pfizer-BioNTech vaccine was authorized for use under an FDA Emergency Use Authorization earlier this year, and the same vaccine assumed the new name, Pfizer-BioNTech Comirnaty, when it was fully approved by the FDA on Sept. 23. The two vaccines may be used interchangeably.

The COVID-19 shot being administered
Air Force Maj. Carla Cox, 59th Medical Wing commander’s executive officer, provides a COVID-19 vaccine to a San Antonio Military Health System beneficiary at Wilford Hall Ambulatory Surgical Center, Joint Base San Antonio-Lackland, Texas. (U.S. Air Force photo by Staff Sgt. Amanda Stanford)

The Comirnaty name (pronounced koe-mir' na tee) was developed from taking the Co from COVID-19, followed by the mRNA in the middle and ending with the 'ty' as a nod to immunity and community.

Third Shot vs. Booster

There is an important distinction between "booster shots" and "an additional dose."

A booster shot of the Pfizer-BioNTech COVID-19 vaccine is recommended for certain individuals at least six months after the second dose of the two dose Pfizer-BioNTech series. A booster shot aims to increase, or "boost", waning immunity observed over time, especially in those 65 years and older and residents of long-term care facilities. A familiar analogy of a booster shot may be the tetanus booster that is recommended every 10 years.

The option for an "additional dose" of mRNA vaccine (Pfizer-BioNTech or Moderna) was recommended in August for a comparatively smaller group of people who have compromised immune systems. This, unlike the booster dose, is because the primary 2-dose series of Pfizer-BioNTech or Moderna may not have resulted in a good enough antibody response; therefore an additional dose is recommended. The timing of an "additional dose" is at least 28 days after the second dose of an mRNA vaccine.

What about Moderna or Janssen Booster Doses?

Health officials may soon make a decision about whether to expand the recommendation for a booster beyond just those who received the Pfizer-BioNTech vaccine.

Moderna has already submitted data to the FDA for booster authorization. "A decision is expected soon," National Institutes of Health Director Francis Collins said Sept. 28. Earlier in September, J&J/Janssen submitted new data in support of a booster for its vaccine.

It's Time to Get Vaccinated

Both FDA and CDC noted that the populations most vulnerable to the SARS-CoV-2 coronavirus that causes COVID-19 continue to be those who are unvaccinated, and the nation's priority should remain getting everyone vaccinated with their primary series.

The approved and authorized COVID-19 vaccines continue to be effective in reducing severe, cases, hospitalizations, and deaths, even against the dominant Delta variant.

Most COVID-19 severe cases, hospitalizations, and deaths occur among the unvaccinated, around 99% of the time.

Hospitalizations rates are 10 to 22 times higher among unvaccinated adults compared to vaccinated adults, according to the CDC.

The CDC's Advisory Committee on Immunization Practices and the FDA Vaccines and Related Biologicals Advisory Committee will continue to follow the scientific data, and evidence will inform booster shot recommendations beyond the current ones.

Experts are looking at all available data to understand how well current vaccines are working for different populations - including looking at new variants Delta and Mu - to see how they affect vaccines' effectiveness.

While the COVID-19 vaccines currently available work to prevent severe illness, hospitalization, and deaths, public health experts are starting to see reduced protection, especially among certain populations, against mild to moderate disease.

"FDA and CDC have determined these booster shots can begin, based on the latest data and evidence, after a thorough, independent and transparent process of evaluating safety and effectiveness," the White House said in a Sept. 24 statement.

You also may be interested in...

DOD experts explain: The science behind the COVID-19 vaccines

Article
2/1/2021
Medical personnel in PPE, conducting lab tests

Six weeks after the first vaccines were approved for emergency use authorization in the U.S., there is much more to know about the vaccine products developed against COVID-19.

Recommended Content:

MHS Toolkits and Branding Guidance | Coronavirus | COVID-19 Vaccine Efforts

COVID-19 Vaccine PSA #3

Video
1/29/2021
COVID-19 Vaccine PSA #3

A Department of Defense Public Service Announcement communicating the Department’s confidence in the safety of the vaccine, confidence in the efficacy of vaccines and transparency in the latest vaccine information. Widespread vaccination against COVID-19 aligns with the Department of Defense’s priorities of protecting service members, DoD civilians, and families; safeguarding national security capabilities; and supporting the whole-of-nation response to the COVID-19 pandemic. (Video by Air Force Staff Sgt. Christopher Duckworth)

Recommended Content:

MHS Toolkits and Branding Guidance | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

COVID-19 Vaccine PSA #5

Video
1/29/2021
COVID-19 Vaccine PSA #5

A Department of Defense Public Service Announcement communicating the importance of maintaining COVID-19 public health safety procedures while the vaccine is distributed, to prevent complacency in COVID-19 mitigation efforts. Widespread vaccination against COVID-19 aligns with the Department of Defense’s priorities of protecting service members, DoD civilians, and families; safeguarding national security capabilities; and supporting the whole-of-nation response to the COVID-19 pandemic. (Video by Air Force Staff Sgt. Christopher Duckworth)

Recommended Content:

MHS Toolkits and Branding Guidance | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

COVID-19 Vaccine PSA #2

Video
1/29/2021
COVID-19 Vaccine PSA #2

A Department of Defense Public Service Announcement communicating that receiving the COVID-19 vaccine provides a quicker return to life. Widespread vaccination against COVID-19 aligns with the Department of Defense’s priorities of protecting service members, DoD civilians, and families; safeguarding national security capabilities; and supporting the whole-of-nation response to the COVID-19 pandemic. (Video by Air Force Staff Sgt. Christopher Duckworth)

Recommended Content:

MHS Toolkits and Branding Guidance | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

COVID-19 Vaccine PSA #4

Video
1/29/2021
COVID-19 Vaccine PSA #4

A Department of Defense Public Service Announcement communicating the Department’s confidence in the vaccine distribution plan and understanding the need for flexibility. Widespread vaccination against COVID-19 aligns with the Department of Defense’s priorities of protecting service members, DoD civilians, and families; safeguarding national security capabilities; and supporting the whole-of-nation response to the COVID-19 pandemic. (Video by Air Force Staff Sgt. Christopher Duckworth)

Recommended Content:

MHS Toolkits and Branding Guidance | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

COVID-19 Vaccine PSA #1

Video
1/29/2021
COVID-19 Vaccine PSA #1

A Department of Defense Public Service Announcement communicating that receiving the COVID-19 vaccine protects yourself, your community, and our nation. Widespread vaccination against COVID-19 aligns with the Department of Defense’s priorities of protecting service members, DoD civilians, and families; safeguarding national security capabilities; and supporting the whole-of-nation response to the COVID-19 pandemic. (Video by Air Force Staff Sgt. Brycen Guerrero)

Recommended Content:

MHS Toolkits and Branding Guidance | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

SAMHS starts next phase of vaccine rollout, expands to 75 and older

Article
1/28/2021
Medical personnel giving a vaccine to a soldier in her right arm

Vaccinations for eligible 1b military personnel will be coordinated by their military units.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | MHS Toolkits and Branding Guidance | MHS Toolkits and Branding Guidance | Coronavirus and the COVID-19 Vaccine

Religious support team deploys to help frontline healthcare workers

Article
1/28/2021
Two military personnel, wearing masks, standing against a wall

Military chaplains and religious affairs specialist deploy to support our military medical providers responding working on the frontlines in response to the COVID-19 pandemic

Recommended Content:

Spiritual Fitness | Total Force Fitness | Coronavirus | Coronavirus and the COVID-19 Vaccine

DHA director visits San Antonio military units, JBSA vaccination sites

Article
1/26/2021
Three military personnel, wearing masks, talking with each other in a hospital hallway

Army Lt. Gen Ronald Place, DHA director, recently visited JBSA vaccination sites and several other military locations in the greater San Antonio region.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

DOD vaccinating personnel worldwide against COVID-19

Article
1/26/2021
Image of two soldiers, wearing masks: one is getting a vaccine in his left arm. Click to open a larger version of the image.

One-month update of COVID-19 distribution and administration efforts to DOD personnel.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | MHS Toolkits and Branding Guidance | Coronavirus and the COVID-19 Vaccine

MHS Transformation results continue during COVID-19

Article
1/21/2021
Military personnel in a supply room, reaching for the top shelf

The MTF transition has enabled the DHA and the Services to increase standardization, eliminate duplicative contracts, and realize cost efficiencies by beginning the management of an enterprise-wide program.

Recommended Content:

Coronavirus | Military Health System Transformation

DOD recommends adults 75 and older should seek COVID-19 vaccine

Article
1/19/2021
Image of nursing home members, wearing masks, waiting in a line to get their COVID vaccine. Click to open a larger version of the image.

This age recommendation differs slightly from that of the Centers for Disease Control and Prevention, which recommends vaccinations for those 65 and older.

Recommended Content:

MHS Toolkits and Branding Guidance | MHS Toolkits and Branding Guidance | Coronavirus | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

LTG Place Vaccine Roll-Out Video

Video
1/18/2021
LTG Place Vaccine Roll-Out Video

DHA Director LTG Ron Place talks about coronavirus vaccines, their safety and efficacy, and encourages everyone to do their own research to get vaccinated.

Recommended Content:

MHS Toolkits and Branding Guidance | MHS Toolkits and Branding Guidance | Coronavirus | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

COVID-19 hinders blood donations during National Blood Donor Month

Article
1/14/2021
Navy Capt. R. Wade Blizzard, commanding officer of U.S. Navy Support Facility Diego Garcia, donates blood for the Navy Medicine Readiness and Training Units Diego Garcia walking blood bank on Dec. 17, 2020. The walking blood bank is a list of eligible donors who can provide blood in case of emergency. (U.S. Navy photo by Navy Seaman Apprentice Stevin Atkins)

Life-saving blood is in high-demand by the Armed Services Blood Program, as the COVID-19 has negatively impacted donations.

Recommended Content:

Armed Services Blood Program | Public Health | Coronavirus

Partnerships, COVID-19 are catalysts for enterprise virtual health

Article
1/14/2021
Image of Mr. Adler with text: "Partnerships, COVID-19 are catalysts for enterprise virtual health."

Jamie Adler, the lead for the DHA’s Virtual Health Clinical Integration Office, discusses the future of virtual health (VH).

Recommended Content:

Coronavirus | Health Care Technology | Coronavirus and the COVID-19 Vaccine
<< < ... 21 22 23 24 25  ... > >> 
Showing results 301 - 315 Page 21 of 34
Refine your search
Last Updated: December 03, 2021

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.